Etanercept related pseudo-empyema in rheumatoid arthritis.
Rimar
Doron
D
Department of Rheumatology, Bnai Zion Medical Center, POB 4940, Haifa, 31048, Israel. doronrimar@gmail.com
Rozenbaum
Michael
M
Slobodin
Gleb
G
Boulman
Nina
N
Rosner
Itzhak
I
D000368:Aged; D018501:Antirheumatic Agents / Q000009:adverse effects* / Q000494:pharmacology; D001172:Arthritis, Rheumatoid / Q000188:drug therapy* / Q000378:metabolism / Q000473:pathology*; D016207:Cytokines / Q000378:metabolism; D000068800:Etanercept; D006801:Humans; D007074:Immunoglobulin G / Q000009:adverse effects* / Q000737:chemistry / Q000494:pharmacology; D007249:Inflammation; D008297:Male; D008954:Models, Biological; D010996:Pleural Effusion / Q000209:etiology* / Q000473:pathology; D018124:Receptors, Tumor Necrosis Factor / Q000737:chemistry / Q000378:metabolism; D016896:Treatment Outcome; D014409:Tumor Necrosis Factor-alpha / Q000378:metabolism
D018501:Antirheumatic Agents; D016207:Cytokines; D007074:Immunoglobulin G; D018124:Receptors, Tumor Necrosis Factor; D014409:Tumor Necrosis Factor-alpha; D000068800:Etanercept